Consensus Report: Definition and Interpretation of Remission in Type 2 DiabetesMatthew C. Riddle, Douglas Twenefour, Michael A. Nauck et al.|Diabetes Care|2021Cited by 417
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialLy‐Mee Yu, Mona Bafadhel, Jienchi Dorward et al.|The Lancet|2021Cited by 310
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trialChristopher Butler, Ly‐Mee Yu, Mona Bafadhel et al.|medRxiv|2021Cited by 28